January 18, 2018 - WHO Collaborating Centre for Governance, Accountability and Transparency for the Pharmaceutical Sector and Health Law, Ethics & Policy Seminar Series

The Benefit and Risks of Expedited Development and Regulatory Approval of New Drugs

Presented by:

Aaron Kesselheim
Associate Professor of Medicine
Harvard Medical School and 
Director, Program on Regulation, Therapeutics, and Law (PORTAL)

Thursday, January 18, 2018 - 12:30 p.m.
84 Queen’s Park, Falconer Hall, Solarium
University of Toronto